Back to User profile » Dr Francis Lobo

Paper published by Dr Francis Lobo:


A Cost per Responder Model for Abatacept versus Adalimumab Among Rheumatoid Arthritis Patients with Seropositivity

Park SH, Han X, Lobo F, Nanji S, Patel D

ClinicoEconomics and Outcomes Research 2020, 12:589-594

Published Date: 15 October 2020